Activator and Type II Diabetics

Inclusion Criteria:

- Subjects will be eligible to participate in the study if they are between the ages of
30-60 and are clinically diagnosed with Type II diabetes by their primary care
providers or endocrinologists (diagnosis usually based on FPG > 126 mg/dL on two
occasions).

- Participants must have been diagnosed for at least one year and currently be under
medical supervision for the disease.

- They must also have an A1c measurement above 7%, which indicates less than optimal
management of the disease.

Exclusion Criteria:

- The study will exclude pregnant women;

- those with co-morbidities affecting life expectancy (e.g. malignancy, CVD);
uncontrolled hypertension (> 150/100 mmHg);

- serious trauma (e.g. MVA) within the previous 12 months;

- diagnosed bleeding/clotting disorders; those currently under chiropractic care or
having contraindications to Activator care (e.g. vertebral fracture, infection,
active inflammatory arthritis, severe osteoporosis).

The presence of these exclusions will be determined during the history and exam
procedures. All female subjects will be asked to take precautions during their
participation in the study to avoid becoming pregnant.